Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Liver » Neoplasms 11. February 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Hepatitis
Liver Cirrhosis
Neoplasms
Portal Hypertension
Others
Gastrointestinal
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3758  Previews Next
   
   Articles 1 - 20 / 75147  
   
Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC.
J Viral Hepat
Guerra-Veloz MF, Shah S, Emmanouil B, Olsen M, George R, Selemani S, Ross PJ, Carey I, Mehta N, Gillyon-Powell M, Agarwal K.
PMID: 41665509 [PubMed - indexed for MEDLINE]


Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis.
Radiology
Lewis S, Wildman-Tobriner B, Cuevas J, Calle S, Bolger I, Wang K, Joshi H, Mankowski Gettle L, Yang JD, Min JH, Sirlin CB, Reeder SB, Bashir MR, Taouli B.
PMID: 41665498 [PubMed - indexed for MEDLINE]


How I Do It: Systemic Therapies for Primary Liver Cancers.
Radiology
Kim TH, Harding JJ, Chernyak V, Mendiratta-Lala M, Lee JM, Do RKG.
PMID: 41665497 [PubMed - indexed for MEDLINE]


Integrated Single-Cell and Bulk Transcriptome Analysis Reveals the Prognostic Significance and Immune Regulatory Mechanisms of Sialylation in Hepatocellular Carcinoma.
FASEB J
Yao Y, Song D, Li M, Wu S, Chen W, Xia H, Xu P.
PMID: 41661103 [PubMed - indexed for MEDLINE]


Survival Outcome Was Better with Liver Resection than with Percutaneous Radiofrequency Ablation in Patients with Very Early-Stage Hepatocellular Carcinoma: A Single-Center Retrospective Study.
J Invest Surg
Yen YH, Liu YW, Hung CH, Chen CH, Kee KM, Li WF, Wang CC, Lu SN, Hu TH, Wang JH, Lin CY.
PMID: 41660702 [PubMed - indexed for MEDLINE]


Assessment of the prevalence and consistency of microvascular flow imaging patterns in focal nodular hyperplasia.
Pathol Oncol Res
Zsély B, Rónaszéki AD, Himsel M, Zsombor Z, Gy, Folhoffer A, Mühl D, Bérczi V, Park BS, Pekli D, Hahn O, Kiss A, Maurovich-Horvat P, Kaposi PN.
PMID: 41660154 [PubMed - indexed for MEDLINE]


Integration of single-cell sequencing, transcriptome sequencing, and machine learning for constructing and validating histone acetylation-related prognostic risk models in hepatocellular carcinoma.
Front Immunol
Qi Y, Wang F, Ren W, Cai C, Zhou Y, Zhu P, He P, Wang Q.
PMID: 41659855 [PubMed - indexed for MEDLINE]


Exploration of safety indicators for radiotherapy in hepatocellular carcinoma: A real-world study.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
Xie X, Zhang X, Peng H, Zhang J, Pan Y, Zhang Z, Jin Q, Cao P.
PMID: 41656812 [PubMed - indexed for MEDLINE]


Clinical Characteristics of Patients With Advanced Hepatocellular Carcinoma Who Transitioned to Subsequent Therapies Following Systemic Therapy.
Cancer Med
Imai K, Takai K, Aiba M, Unome S, Miwa T, Hanai T, Sakai H, Shirakami Y, Suetsugu A, Shimizu M.
PMID: 41656177 [PubMed - indexed for MEDLINE]


The Clinical Impact of Cardiovascular Thrombosis on Overall Survival in Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization.
Cancer Med
Fujita K, Takuma K, Nakahara M, Suto H, Morishita A, Himoto T, Okano K, Kobara H.
PMID: 41656171 [PubMed - indexed for MEDLINE]


Comparative efficacy of combination regimens based on interventional therapy and immune checkpoint inhibitors (ICIs) in patients with intermediate- and advanced-stage hepatocellular carcinoma: a systematic review, meta-analysis, and network meta-analysis.
Cancer Immunol Immunother
Su J, Su Y, Mai R, Gao X, Li S, Zeng D, Cen W, Huang Z, Li X, Zeng H, Li W, Zeng C, Wu T, Mo K, Ye J, Lin Y, Liang R.
PMID: 41653198 [PubMed - indexed for MEDLINE]


A new, machine learning-based approach to metastatic neuroendocrine tumors of unknown origin.
J Neuroendocrinol
Lü J, Amin T, Clauditz T, Steinkraus K, Buchstab O, Huber S, Izbicki J, Fründt T, Schrader J, Werner R, Schmitz R.
PMID: 41652828 [PubMed - indexed for MEDLINE]


A Deep Learning Algorithm for Liver Metastasis Detection at Contrast-enhanced Abdominal CT in Patients with Colorectal Cancer: A Comparative Study with Radiologists.
Radiol Imaging Cancer
Sartoris R, Paisant A, Bône A, Nicolas F, Malakzadeh S, Matteini F, Dioguardi Burgio M, Vilgrain V, Ronot M, Aubé C.
PMID: 41649392 [PubMed - indexed for MEDLINE]


T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy.
J Cell Mol Med
Nouri K, Asadollahei N, Haghir-Sharif-Zamini Y, Seydi H, Salehi M, Mesdaghi M, Najimi M, Vosough M.
PMID: 41645702 [PubMed - indexed for MEDLINE]


Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy.
Technol Cancer Res Treat
Zhong D, Liang Y, Su Y, Yang Q, Yan H, Huang X, Shang J.
PMID: 41642855 [PubMed - indexed for MEDLINE]


A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series.
Cancer Med
Liava C, Venkatesh S, Torbenson MS, Kamath PS, Hilscher M.
PMID: 41641648 [PubMed - indexed for MEDLINE]


Treatment-related differences in quality of life and psychological distress among patients with hepatocellular carcinoma: A cross-sectional analysis.
Palliat Support Care
Tsai YT, Lu ZT, Kuo HY, Yang YH, Tsai YJ, Tsai KF, Liu WC.
PMID: 41641613 [PubMed - indexed for MEDLINE]


Synergistic anti-hepatoma effect of triptolide and quercetin via co-inhibition and interaction with Janus kinase and mammalian target of rapamycin signal pathway.
World J Gastroenterol
Tong HX, Zhang JL, Nie WY, Jiang LJ, Hu JQ, Lu T.
PMID: 41640866 [PubMed - indexed for MEDLINE]


Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials.
World J Gastroenterol
Ascari S, Chen R, De Sinno A, Stefanini B, Cescon M, Serenari M, Mosconi C, Tovoli F.
PMID: 41640611 [PubMed - indexed for MEDLINE]


Stemness CD24 activation promotes hepatocellular carcinoma progression via an immune escape mechanism.
World J Gastroenterol
Cai Y, Liu LY, Xia XX, Tang H, Xu M, Sai WL, Yao DF, Yao M.
PMID: 41640606 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 75147    Page 1 of 3758  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1